1099 Share Price Performance
HK$16.92
-1.68 (-9.03%)
2.5% overvalued intrinsic discount
HK$16.50
Fair Value
Price HK$16.92
kapirey HK$16.50
Fair ValueHK$16.50
Share Pricen/a
Narrative Update • May 26
Sinopharm Group Co. Ltd. Stock Price
- 1 Narratives written by author
- 0 Comments on narratives written by author
- 13 Fair Values set on narratives written by author
1099 Community Narratives
KA
Fair Value
·Fair Value HK$16.5 2.5% overvalued intrinsic discount
value + defensive emerging markets healthcare
0users have liked this narrative
0users have commented on this narrative
2users have followed this narrative
value + defensive emerging markets healthcare
China’s biggest medicine distributor looks more like a utility than a growth story: it keeps supplies moving to hospitals and pharmacies, even as pandemic-era demand fades. The appeal is its scale, broad reach across devices and retail pharmacies, and a shareholder-friendly payout—balanced against tight profits and heavy pressure from government pricing rules.Read more
Trending Discussion
Recently Updated Narratives
KA
value + defensive emerging markets healthcare
Fair Value: HK$16.5 2.5% overvalued intrinsic discount
2 fair values setusers have set this as their fair value
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
Snowflake Analysis
Sinopharm Group Co. Ltd. Key Details
About 1099
- Founded
- 2003
- Employees
- 94910
- CEO
- WebsiteView website
Sinopharm Group Co. Ltd., together with its subsidiaries, engages in the wholesale and retail of pharmaceutical and healthcare products, and medical devices in the People’s Republic of China. The company operates through four segments: Pharmaceutical Distribution, Medical Devices Distribution, Retail Pharmacy, and Other Business. The Pharmaceutical Distribution segment distributes pharmaceutical products to hospitals, other distributors, retail pharmacy stores, and clinics. This segment also offers distribution, logistics, and other value-added services for domestic and international pharmaceutical and healthcare products manufacturers, and other suppliers. The Medical Devices Distribution segment distributes medical devices, as well as provides installation and maintenance services. The Retail Pharmacy segment operates and franchises a network of retail drug stores. The Other Business segment engages in the distribution of laboratory supplies; manufacture and distribution of chemical reagents; and production and sale of pharmaceutical products. The company rents and manages properties; distributes medical instruments and equipment, Chinese herbal medicines, antibiotics, and biological products; and offers information technology, investment, goods and technology import and export, business consulting, health consultation, medical consulting, market information consulting and investigation, and convention and exhibition services. It also manages medical project investment, consulting, and technology training activities; and manufactures medicines. Sinopharm Group Co. Ltd. was founded in 2003 and is headquartered in Shanghai, the People’s Republic of China. Sinopharm Group Co. Ltd. is a subsidiary of Sinopharm Industrial Investment Co., Ltd.
